Drug-induced kidney diseases

Journal of Association of Physicians of India

Volumn 51, Issue OCT, 2003, Pages 970-979

  Singh, N P ^a   Ganguli, A ^a   Prakash, A ^a  

^a LOK NAYAK HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICALLY INDUCED DISORDER; DRUG EFFECT; HUMAN; KIDNEY; KIDNEY DISEASE; REVIEW;

HUMANS; KIDNEY; KIDNEY DISEASES;

EID: 1242263931     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Jha V, Chugh KS. Drug induced renal disease. J Assoc Physicians India 1995;43:407-21.
2. Luft FC. Clinical significance of renal changes engendered by aminoglycosides in man. J Antimicrob Chemother 1984;13(suppl A):23-30.
3. Gilbert DN. Once-daily aminoglycoside therapy. Antimicrob Agents Chemother 1991;35:399-405.
4. Farber BF, Moellering RC Jr. Retrospective study of toxicity of preparations of vancomycin from 1974 to 1981. Antimicrob Agents Chemother 1983;23:138-41.
5. Sorrell TC, Collignon PJ. A prospective study of adverse reactions associated with vancomycin. J Antimicrob Chemother 1985;16:235-41.
6. Weinstein L, Madoff MA, Samet CM. The sulfonamides. N Eng J Med 1960;263:793-800 and 952-7.
7. Beyhand F, et al. Effect of TMP-SMZ on renal secretion of creatinine in man. J Urol 1975;114:802-8.
8. Buchanan N. Sulfamethoxazole, hypoalbuminema, crystalluria and renal failure. Br Med J 1978;2:172.
9. Choi MJ, Fernandez PC, Patnaik A, et al. Brief report: trimethoprim induced hyperkalemia in a patient with AIDS. N Eng J Med 1993;328:703-6.
10. Krieble BF, Rudy DW, Glick MR, Clayman MD. Case report: Acyclovir neurotoxicity and nephrotoxicity - a role for hemodialysis. Am J Med Sci 1993;305:36-9.
11. Androcoli TE, Mohahan M. The interaction of polyene antibiotics with thin lipid membranes. J Gen Physiol 1968;52:300-25.
12. Wasan KM, Vadiei K, Lopez-Berestein G, Verani RR, Luke DR. Pentoxyphylline in amphotericin B toxicity rat model. Antimicrobial Agents Chemother 1990;34:241-4.
13. Reiner NE, Thompson WL. Dopamine and saralasin antagonism of renal vasoconstriction and oliguria caused by amphotericin B in dogs. J Infect Dis 1979;140:564-75.
14. Ohnishi A, Ohnishi T, Stevenhead W, et al. Sodium status influences chronic amphotericin-B nephrotoxicity in rats. Antimicrob Agents Chemother 1989;33:1222-7.
15. Hiemenz JW, Walsh TJ. Lipid formulations of amphotericin B: recent progress and future directions. Clinical Infect Dis 1996;22 (Suppl 2):S133-44.
16. Prakash J, Kumar NS, Saxena RK, Verma U. Acute renal failure complicating rifampicin therapy. J Assoc Physicians India 2001;49:877-80.
17. DeVriese AS, Robbrecht DL, Vanholder RC, Vogelaers DP, Lameire NH. Rifampicin-associated acute renal failure: pathophysiologic, immunologic and clinical features. Am J Kid Dis 1998;31:108-15.
18. Power DA, Russell G, Smith FW, et al. Acute renal failure due to continuous rifampicin. Lin Nephrol 1983;20:155-9.
19. Covic A, Goldsmith DJ, Segall L, et al. Rifampicin-induced acute renal failure: a series of 60 patients. Nephrol Dial Transplant 1998;13:924-9.
20. Agnihotri MS, Bansal S, Kumar A. Acute renal failure due to rifampicin. Indian J Chest Dis Allied Sci 1990;32:125-8.
21. Beckmann ML, Gerber JG, Byyny RL, Loverde M, Nies AS. Propranolol increases prostacyclin synthesis in patients with hypertension. Hypertension 1988;12:582-8.
22. Seelig CB, Maloley PA, Campbell JR. Nephrotoxicity associated with concomitant ACE inhibitor and NSAID therapy. South Med J 1990;83:1144-8.
23. Pope JE, Anderson JJ, Felson DT. A meta-analysis of the effect of nonsteroidal anti-inflammatory drugs on blood pressure. Arch Int Med 1993;153:477-84.
24. Morgenstern SJ, Bruns FJ, Fraley DS, Kirsch M, Borochoitz D. Ibuprofen-associated lipoid nephrosis without interstitial nephritis. Am J Kidney Dis 1989;14:50-2.
25. Elseviers MM, De Schepper A, Corthouts R, et al. High diagnostic performance of CT scan for analgesic nephropathy in patients with incipient to severe renal failure. Kidney Int 1995;48:1316-23.
26. Komers R, Anderson S, Epstein M. Renal and cardiovascular effects of selective cyclooxygenase-2 inhibitors. Am J Kidney Dis 2001;38:1145-57.
27. Feehally J, Walls J, Mistry N, et al. Does nifedipine ameliorate cyclosporin A nephrotoxicity? Br Med J 1987;295:310.
28. Mudge GH. Nephrotoxicity of urographic radiocontrast drugs. Kidney Int 1980;18:540-52.
29. Barrett BJ, Carlisle EJ. Meta-analysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 1993;188:171-8.
30. Morcos SK, Thomsen HS, Webb JA. Contrast media induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). Eur Radiol 1999;9:1602-13.